Hirtle Callaghan & CO LLC Johnson & Johnson Transaction History

Hirtle Callaghan & CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $1.71 Million - $2.04 Million	-11,333 Reduced 87.13%	1,674 $259,000
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $1 Million - $1.13 Million	6,270 Added 93.07%	13,007 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $248,286 - $276,281	-1,539 Reduced 18.6%	6,737 $1.1 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $87,626 - $96,911	-521 Reduced 5.92%	8,276 $1.47 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $847,788 - $962,781	5,361 Added 156.02%	8,797 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $535,775 - $594,462	3,436 New	3,436 $588,000
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $1.84 Million - $2.04 Million	-14,600 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$131.22 - $143.62 $52,750 - $57,735	-402 Reduced 2.68%	14,600 $2.04 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $1.94 Million - $2.03 Million	15,002	15,002 $1.95 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.